Valneva SE (VALN) Change in Intangibles (2021 - 2026)
Valneva SE (VALN) posted Change in Intangibles of -$5853.7 for Q1 2026, down 151.71% sequentially from $11319.6 in Q2 2025, and up 92.16% YoY from -$3046.2 in Q1 2025.
Analysis
Valneva SE (VALN) Change in Intangibles (2021 - 2026) Analysis & Trends
Valneva SE has reported Change in Intangibles for 6 years, with the latest figure at -$5853.7 in Q1 2026.
- Quarterly Change in Intangibles rose 92.16% year-over-year to -$5853.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$69217.9 (up 7.32% YoY) and the FY2024 annual result came in at $98.3 million, up 112303.86% from the prior year.
- Change in Intangibles declined to -$5853.7 in Q1 2026 per VALN's latest filing, from $11319.6 in the prior quarter.
- Over five years, Change in Intangibles peaked at $98.7 million in Q1 2024 and troughed at -$87151.1 in Q4 2023.
- A 5-year average of $16.4 million and a median of -$40268.8 in 2025 frame the typical range for Change in Intangibles.
- The sharpest annual moves came in 2025 and 2026: Change in Intangibles plunged 100.08% in 2025, then surged 92.16% in 2026.
- Over 5 years, Change in Intangibles stood at -$85297.7 in 2022, then decreased by 2.17% to -$87151.1 in 2023, then surged by 113325.72% to $98.7 million in 2024, then plunged by 99.99% to $11319.6 in 2025, then plunged by 151.71% to -$5853.7 in 2026.
- According to Business Quant data, Change in Intangibles over the past three periods registered -$5853.7, $11319.6, and -$74683.8 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -5,853.73 |
| Jun 30, 2025 | 11,319.60 |
| Mar 31, 2025 | -74,683.80 |
| Mar 31, 2024 | 98.68 Mn |
| Dec 31, 2023 | -87,151.13 |
| Mar 31, 2022 | -85,297.67 |
| Dec 31, 2021 | -4,575.88 |
| Sep 30, 2021 | -208,733.86 |